Skip to Content
Merck
CN

P26406

2-Phenyl-1,3-indandione

97%

Synonym(s):

2-Phenyl-1H-indene-1,3(2H)-dione, Phenindione

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
C15H10O2
CAS Number:
83-12-5
Molecular Weight:
222.24
EC Number:
201-454-4
UNSPSC Code:
12352100
PubChem Substance ID:
24898344
Beilstein/REAXYS Number:
1911699
MDL number:
MFCD00003782
Assay:
97%
Form:
crystals

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI key

NFBAXHOPROOJAW-UHFFFAOYSA-N

InChI

1S/C15H10O2/c16-14-11-8-4-5-9-12(11)15(17)13(14)10-6-2-1-3-7-10/h1-9,13H

SMILES string

O=C1C(c2ccccc2)C(=O)c3ccccc13

assay

97%

form

crystals

Gene Information

human ... VKORC1(79001)

mp

144-148 °C (lit.)

pictograms

Skull and crossbones
GHS06

signalword

Danger

hcodes

H301,H317

Hazard Classifications

Acute Tox. 3 Oral - Skin Sens. 1

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
14926CQ
09923CW

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

C Merklen-Djafri et al.
Annales de dermatologie et de venereologie, 139(3), 199-203 (2012-03-10)
Cutaneous necrosis is a rare complication of vitamin K antagonist therapy. It presents as cutaneous hemorrhagic necrosis and usually occurs at the start of treatment. We describe an atypical case of recurrent skin necrosis after two years of treatment with
[Bleedings during vitamin K antagonist therapy associated with ciclosporin and rifampicin].
Laurent Chouchana et al.
Presse medicale (Paris, France : 1983), 42(5), 908-911 (2012-10-17)
Gérard Cam et al.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 27(4), 1554-1558 (2011-09-21)
Among the vitamin K antagonists (VKA), indanedione-derived VKA is suspected to induce an immunoallergic risk. One indanedione-derived VKA, fluindione, is still being used in France. The aim of this study was to evaluate the contribution of VKA to acute and
Amélie Daveluy et al.
European journal of clinical pharmacology, 68(1), 101-105 (2011-07-28)
Fluindione is an oral vitamin K antagonist (indanedione derivative) exclusively marketed in France and Luxembourg, known to have immuno-allergic adverse effects such as hepatitis, fever or interstitial nephritis. A few cases of drug reaction with eosinophilia and systemic symptoms (DRESS)
P Gelot et al.
Annales de dermatologie et de venereologie, 139(4), 282-286 (2012-04-10)
Antiphospholipid syndrome (APS) is characterised by arterial or venous thrombosis combined with the presence of specific antibodies known as antiphospholipids. It is commonly associated with cutaneous signs. Herein we report a case of atypical cutaneous eruption occurring during the course
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service